Case Study: Ofatumumab-Induced Remission in Refractory Panuveitis Accompanied by Multiple Sclerosis

• by Agni M. Konitsioti, Jeany Q. Lammert, Sabine Vay, Gereon R. Fink, Michael Schroeter, Clemens Warnke

• April 29, 2026

QuantiFERON-TB Gold Assay: An Effective Diagnostic Approach for Tubercular Uveitis in Non-Endemic Areas

• by Sebastian Albus, Antonia Koch, Uwe Pleyer, Anne Rübsam, Leif E. Sander, Martin Witzenrath, Nikolai Menner, Lynn S. zur Bonsen, Dominika Pohlmann

• April 17, 2026

EULAR Updates Behçet’s Syndrome Recommendations

EULAR releases updated recommendations supporting earlier biologic use in patients with eye, vascular, and nervous system involvement

• by Kathryn Wighton

• April 1, 2026

• 5 min

Tattoo-Associated Uveitis: What Primary Eye Care Needs to Know in 2026

Drs. Cass and Wolfe review recent research on tattoo-associated uveitis and offer practcal takeaways in uveitis cases.

• by Peter Cass, OD, Christopher Wolfe, OD, FAAO

• May 1, 2026

• 11 min